Industry Research Reports

Home > Reports > Service & Software > Personalized Medicines - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Personalized Medicines - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Industry: Service & Software

Published Date: 2026-07-15

Pages: 139 Pages

Report ld: 6973796

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Personalized Medicines Market Size(US$)

CAGR 2026-2032

10.9%

Market Size,2032

USD 714,300

Million

Market Snapshot

Market Size in 2026 (Value)

US$ 385,010 million

Market Forecast in 2032(Value)

US$ 714,300 million

CAGR

10.9%

Years Considered

2021-2032

Base Year

2026

Forecast Period

2026-2032

Source: Secondary research, interviews with experts, and QYResearch analysis

The global market for Personalized Medicines was estimated to be worth US$ 350760 million in 2025 and is projected to reach US$ 714300 million, growing at a CAGR of 10.9% from 2026 to 2032.

Personalized medicine is tailoring of a treatment to a specific patient i.e. designing medicine treatment on the basis of diagnosis, disease condition, patient history, body physics, and other factors related to patients and diseases. Personalized medicine is also known as precision medicine, stratified medicine, or P4 medicine.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report provides a comprehensive view of the global market for Personalized Medicines, covering total sales revenue, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.

The Personalized Medicines market size, estimations, and forecasts are presented in terms of sales revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Personalized Medicines.

MARKET SEGMENTATION

By Company

3G Biotech
Quest Diagnostics
Laboratory Corporation of America
Abbott
Agendia NV
Asuragen Inc
Becton Dickinson
CardioDx Inc.
Foundation Medicine
Qiagen
Siemens Healthcare
Amgen
Bristol-Myers Squibb
GE Healthcare
Pfizer
Sanofi
23andMe
Illumina

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

PM Diagnostics
PM Therapeutics
Personalized Medical Care
Personalized Nutrition & Wellness

Segment by Application

Hospitals Pharmacies
Retail Pharmacies
Dietary Care Centers
Others

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the scope of the report and the global market size (value). It also summarizes market dynamics and recent developments; identifies key drivers and restraints; outlines challenges and risks for players; reviews relevant industry policies.

Chapter 2: Provides a detailed analysis of the Personalized Medicines companies' competitive landscape—including revenue shares, recent development plans, and mergers and acquisitions (M&A).

Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.

Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.

Chapter 5: Presents Personalized Medicines revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.

Chapter 6: Presents Personalized Medicines revenue at the country level. It provides segmented data by Type and by Application for each country/region.

Chapter 7: Profiles key players, detailing the main companies' product revenue, gross margin, product portfolios, recent developments, etc.

Chapter 8: Analysis of Value Chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Personalized Medicines Product Introduction

1.2 Global Personalized Medicines Market Size Forecast (2021–2032)

1.3 Personalized Medicines Market Trends & Drivers

1.3.1 Personalized Medicines Industry Trends

1.3.2 Personalized Medicines Market Drivers & Opportunities

1.3.3 Personalized Medicines Market Challenges

1.3.4 Personalized Medicines Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Personalized Medicines Players Revenue Ranking (2025)

2.2 Global Personalized Medicines Revenue by Company (2021–2026)

2.3 Key Companies’ R&D and Operations Footprint and Headquarters

2.4 Key Companies Personalized Medicines Product Offerings

2.5 Key Companies General Availability (GA) Timeline for Personalized Medicines

2.6 Personalized Medicines Market Competitive Analysis

2.6.1 Personalized Medicines Market Concentration Rate (2021–2026)

2.6.2 Top 5 and Top 10 Global Companies by Personalized Medicines Revenue in 2025

2.6.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Personalized Medicines revenue, 2025

2.7 Mergers & Acquisitions and Expansion

3 Segmentation Personalized Medicines Market Classification

3.1 Introduction by Type

3.1.1 PM Diagnostics

3.1.2 PM Therapeutics

3.1.3 Personalized Medical Care

3.1.4 Personalized Nutrition & Wellness

3.1.5 Global Personalized Medicines Sales Value by Type

3.1.5.1 Global Personalized Medicines Sales Value by Type (2021 vs 2025 vs 2032)

3.1.5.2 Global Personalized Medicines Sales Value, by Type (2021–2032)

3.1.5.3 Global Personalized Medicines Sales Value, by Type (%), 2021–2032

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Hospitals Pharmacies

4.1.2 Retail Pharmacies

4.1.3 Dietary Care Centers

4.1.4 Others

4.2 Global Personalized Medicines Sales Value by Application

4.2.1 Global Personalized Medicines Sales Value by Application (2021 vs 2025 vs 2032)

4.2.2 Global Personalized Medicines Sales Value by Application (2021–2032)

4.2.3 Global Personalized Medicines Sales Value by Application (%), 2021–2032

5 Segmentation by Region

5.1 Global Personalized Medicines Sales Value by Region

5.1.1 Global Personalized Medicines Sales Value by Region: 2021 vs 2025 vs 2032

5.1.2 Global Personalized Medicines Sales Value by Region (2021–2026)

5.1.3 Global Personalized Medicines Sales Value by Region (2027–2032)

5.1.4 Global Personalized Medicines Sales Value by Region (%), 2021–2032

5.2 North America

5.2.1 North America Personalized Medicines Sales Value, 2021–2032

5.2.2 North America Personalized Medicines Sales Value by Country (%), 2025 vs 2032

5.3 Europe

5.3.1 Europe Personalized Medicines Sales Value, 2021–2032

5.3.2 Europe Personalized Medicines Sales Value by Country (%), 2025 vs 2032

5.4 Asia Pacific

5.4.1 Asia Pacific Personalized Medicines Sales Value, 2021–2032

5.4.2 Asia Pacific Personalized Medicines Sales Value by Subregion (%), 2025 vs 2032

5.5 South America

5.5.1 South America Personalized Medicines Sales Value, 2021–2032

5.5.2 South America Personalized Medicines Sales Value by Country (%), 2025 vs 2032

5.6 Middle East & Africa

5.6.1 Middle East & Africa Personalized Medicines Sales Value, 2021–2032

5.6.2 Middle East & Africa Personalized Medicines Sales Value by Country (%), 2025 vs 2032

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Personalized Medicines Sales Value Growth Trends, 2021 vs 2025 vs 2032

6.2 Key Countries/Regions Personalized Medicines Sales Value, 2021–2032

6.3 United States

6.3.1 United States Personalized Medicines Sales Value, 2021–2032

6.3.2 United States Personalized Medicines Sales Value by Type (%), 2025 vs 2032

6.3.3 United States Personalized Medicines Sales Value by Application, 2025 vs 2032

6.4 Europe

6.4.1 Europe Personalized Medicines Sales Value, 2021–2032

6.4.2 Europe Personalized Medicines Sales Value by Type (%), 2025 vs 2032

6.4.3 Europe Personalized Medicines Sales Value by Application, 2025 vs 2032

6.5 China

6.5.1 China Personalized Medicines Sales Value, 2021–2032

6.5.2 China Personalized Medicines Sales Value by Type (%), 2025 vs 2032

6.5.3 China Personalized Medicines Sales Value by Application, 2025 vs 2032

6.6 Japan

6.6.1 Japan Personalized Medicines Sales Value, 2021–2032

6.6.2 Japan Personalized Medicines Sales Value by Type (%), 2025 vs 2032

6.6.3 Japan Personalized Medicines Sales Value by Application, 2025 vs 2032

6.7 South Korea

6.7.1 South Korea Personalized Medicines Sales Value, 2021–2032

6.7.2 South Korea Personalized Medicines Sales Value by Type (%), 2025 vs 2032

6.7.3 South Korea Personalized Medicines Sales Value by Application, 2025 vs 2032

6.8 Southeast Asia

6.8.1 Southeast Asia Personalized Medicines Sales Value, 2021–2032

6.8.2 Southeast Asia Personalized Medicines Sales Value by Type (%), 2025 vs 2032

6.8.3 Southeast Asia Personalized Medicines Sales Value by Application, 2025 vs 2032

6.9 India

6.9.1 India Personalized Medicines Sales Value, 2021–2032

6.9.2 India Personalized Medicines Sales Value by Type (%), 2025 vs 2032

6.9.3 India Personalized Medicines Sales Value by Application, 2025 vs 2032

7 Company Profiles

7.1 3G Biotech

7.1.1 3G Biotech Profile

7.1.2 3G Biotech Main Business

7.1.3 3G Biotech Personalized Medicines Products, Services, and Solutions

7.1.4 3G Biotech Personalized Medicines Revenue (US$ Million), 2021–2026

7.1.5 3G Biotech Recent Developments

7.2 Quest Diagnostics

7.2.1 Quest Diagnostics Profile

7.2.2 Quest Diagnostics Main Business

7.2.3 Quest Diagnostics Personalized Medicines Products, Services, and Solutions

7.2.4 Quest Diagnostics Personalized Medicines Revenue (US$ Million), 2021–2026

7.2.5 Quest Diagnostics Recent Developments

7.3 Laboratory Corporation of America

7.3.1 Laboratory Corporation of America Profile

7.3.2 Laboratory Corporation of America Main Business

7.3.3 Laboratory Corporation of America Personalized Medicines Products, Services, and Solutions

7.3.4 Laboratory Corporation of America Personalized Medicines Revenue (US$ Million), 2021–2026

7.3.5 Laboratory Corporation of America Recent Developments

7.4 Abbott

7.4.1 Abbott Profile

7.4.2 Abbott Main Business

7.4.3 Abbott Personalized Medicines Products, Services, and Solutions

7.4.4 Abbott Personalized Medicines Revenue (US$ Million), 2021–2026

7.4.5 Abbott Recent Developments

7.5 Agendia NV

7.5.1 Agendia NV Profile

7.5.2 Agendia NV Main Business

7.5.3 Agendia NV Personalized Medicines Products, Services, and Solutions

7.5.4 Agendia NV Personalized Medicines Revenue (US$ Million), 2021–2026

7.5.5 Agendia NV Recent Developments

7.6 Asuragen Inc

7.6.1 Asuragen Inc Profile

7.6.2 Asuragen Inc Main Business

7.6.3 Asuragen Inc Personalized Medicines Products, Services, and Solutions

7.6.4 Asuragen Inc Personalized Medicines Revenue (US$ Million), 2021–2026

7.6.5 Asuragen Inc Recent Developments

7.7 Becton Dickinson

7.7.1 Becton Dickinson Profile

7.7.2 Becton Dickinson Main Business

7.7.3 Becton Dickinson Personalized Medicines Products, Services, and Solutions

7.7.4 Becton Dickinson Personalized Medicines Revenue (US$ Million), 2021–2026

7.7.5 Becton Dickinson Recent Developments

7.8 CardioDx Inc.

7.8.1 CardioDx Inc. Profile

7.8.2 CardioDx Inc. Main Business

7.8.3 CardioDx Inc. Personalized Medicines Products, Services, and Solutions

7.8.4 CardioDx Inc. Personalized Medicines Revenue (US$ Million), 2021–2026

7.8.5 CardioDx Inc. Recent Developments

7.9 Foundation Medicine

7.9.1 Foundation Medicine Profile

7.9.2 Foundation Medicine Main Business

7.9.3 Foundation Medicine Personalized Medicines Products, Services, and Solutions

7.9.4 Foundation Medicine Personalized Medicines Revenue (US$ Million), 2021–2026

7.9.5 Foundation Medicine Recent Developments

7.10 Qiagen

7.10.1 Qiagen Profile

7.10.2 Qiagen Main Business

7.10.3 Qiagen Personalized Medicines Products, Services, and Solutions

7.10.4 Qiagen Personalized Medicines Revenue (US$ Million), 2021–2026

7.10.5 Qiagen Recent Developments

7.11 Siemens Healthcare

7.11.1 Siemens Healthcare Profile

7.11.2 Siemens Healthcare Main Business

7.11.3 Siemens Healthcare Personalized Medicines Products, Services, and Solutions

7.11.4 Siemens Healthcare Personalized Medicines Revenue (US$ Million), 2021–2026

7.11.5 Siemens Healthcare Recent Developments

7.12 Amgen

7.12.1 Amgen Profile

7.12.2 Amgen Main Business

7.12.3 Amgen Personalized Medicines Products, Services, and Solutions

7.12.4 Amgen Personalized Medicines Revenue (US$ Million), 2021–2026

7.12.5 Amgen Recent Developments

7.13 Bristol-Myers Squibb

7.13.1 Bristol-Myers Squibb Profile

7.13.2 Bristol-Myers Squibb Main Business

7.13.3 Bristol-Myers Squibb Personalized Medicines Products, Services, and Solutions

7.13.4 Bristol-Myers Squibb Personalized Medicines Revenue (US$ Million), 2021–2026

7.13.5 Bristol-Myers Squibb Recent Developments

7.14 GE Healthcare

7.14.1 GE Healthcare Profile

7.14.2 GE Healthcare Main Business

7.14.3 GE Healthcare Personalized Medicines Products, Services, and Solutions

7.14.4 GE Healthcare Personalized Medicines Revenue (US$ Million), 2021–2026

7.14.5 GE Healthcare Recent Developments

7.15 Pfizer

7.15.1 Pfizer Profile

7.15.2 Pfizer Main Business

7.15.3 Pfizer Personalized Medicines Products, Services, and Solutions

7.15.4 Pfizer Personalized Medicines Revenue (US$ Million), 2021–2026

7.15.5 Pfizer Recent Developments

7.16 Sanofi

7.16.1 Sanofi Profile

7.16.2 Sanofi Main Business

7.16.3 Sanofi Personalized Medicines Products, Services, and Solutions

7.16.4 Sanofi Personalized Medicines Revenue (US$ Million), 2021–2026

7.16.5 Sanofi Recent Developments

7.17 23andMe

7.17.1 23andMe Profile

7.17.2 23andMe Main Business

7.17.3 23andMe Personalized Medicines Products, Services, and Solutions

7.17.4 23andMe Personalized Medicines Revenue (US$ Million), 2021–2026

7.17.5 23andMe Recent Developments

7.18 Illumina

7.18.1 Illumina Profile

7.18.2 Illumina Main Business

7.18.3 Illumina Personalized Medicines Products, Services, and Solutions

7.18.4 Illumina Personalized Medicines Revenue (US$ Million), 2021–2026

7.18.5 Illumina Recent Developments

8 Industry Chain Analysis

8.1 Personalized Medicines Value Chain

8.2 Personalized Medicines Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Key Suppliers of Raw Materials

8.2.3 Cost Structure

8.3 Midstream Analysis

8.4 Downstream (Customer) Analysis

8.5 Sales Model and Sales Channelss

8.5.1 Personalized Medicines Sales Model

8.5.2 Sales Channels

8.5.3 Personalized Medicines Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Personalized Medicines Market Trends

Table 2. Personalized Medicines Market Drivers & Opportunities

Table 3. Personalized Medicines Market Challenges

Table 4. Personalized Medicines Market Restraints

Table 5. Global Personalized Medicines Revenue by Company (US$ Million), 2021–2026

Table 6. Global Personalized Medicines Revenue Market Share by Company (2021–2026)

Table 7. Key Companies’ R&D and Operations Footprint and Headquarters

Table 8. Key Companies Personalized Medicines Product Type

Table 9. Key Companies General Availability (GA) Timeline for Personalized Medicines

Table 10. Global Personalized Medicines Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Personalized Medicines revenue, 2025

Table 12. Mergers & Acquisitions and Expansion Plans

Table 13. Global Personalized Medicines Sales Value by Type: 2021 vs 2025 vs 2032 (US$ Million)

Table 14. Global Personalized Medicines Sales Value by Type (US$ Million), 2021–2026

Table 15. Global Personalized Medicines Sales Value by Type (US$ Million), 2027–2032

Table 16. Global Personalized Medicines Sales Market Share in Value by Type (2021–2026)

Table 17. Global Personalized Medicines Sales Market Share in Value by Type (2027–2032)

Table 18. Global Personalized Medicines Sales Value by Application: 2021 vs 2025 vs 2032 (US$ Million)

Table 19. Global Personalized Medicines Sales Value by Application (US$ Million), 2021–2026

Table 20. Global Personalized Medicines Sales Value by Application (US$ Million), 2027–2032

Table 21. Global Personalized Medicines Sales Market Share in Value by Application (2021–2026)

Table 22. Global Personalized Medicines Sales Market Share in Value by Application (2027–2032)

Table 23. Global Personalized Medicines Sales Value by Region, (US$ Million), 2021 vs 2025 vs 2032

Table 24. Global Personalized Medicines Sales Value by Region (US$ Million), 2021–2026

Table 25. Global Personalized Medicines Sales Value by Region (US$ Million), 2027–2032

Table 26. Global Personalized Medicines Sales Value by Region (%), 2021–2026

Table 27. Global Personalized Medicines Sales Value by Region (%), 2027–2032

Table 28. Key Countries/Regions Personalized Medicines Sales Value Growth Trends, (US$ Million): 2021 vs 2025 vs 2032

Table 29. Key Countries/Regions Personalized Medicines Sales Value, (US$ Million), 2021–2026

Table 30. Key Countries/Regions Personalized Medicines Sales Value, (US$ Million), 2027–2032

Table 31. 3G Biotech Basic Information List

Table 32. 3G Biotech Description and Business Overview

Table 33. 3G Biotech Personalized Medicines Products, Services, and Solutions

Table 34. Revenue (US$ Million) in Personalized Medicines Business of 3G Biotech (2021–2026)

Table 35. 3G Biotech Recent Developments

Table 36. Quest Diagnostics Basic Information List

Table 37. Quest Diagnostics Description and Business Overview

Table 38. Quest Diagnostics Personalized Medicines Products, Services, and Solutions

Table 39. Revenue (US$ Million) in Personalized Medicines Business of Quest Diagnostics (2021–2026)

Table 40. Quest Diagnostics Recent Developments

Table 41. Laboratory Corporation of America Basic Information List

Table 42. Laboratory Corporation of America Description and Business Overview

Table 43. Laboratory Corporation of America Personalized Medicines Products, Services, and Solutions

Table 44. Revenue (US$ Million) in Personalized Medicines Business of Laboratory Corporation of America (2021–2026)

Table 45. Laboratory Corporation of America Recent Developments

Table 46. Abbott Basic Information List

Table 47. Abbott Description and Business Overview

Table 48. Abbott Personalized Medicines Products, Services, and Solutions

Table 49. Revenue (US$ Million) in Personalized Medicines Business of Abbott (2021–2026)

Table 50. Abbott Recent Developments

Table 51. Agendia NV Basic Information List

Table 52. Agendia NV Description and Business Overview

Table 53. Agendia NV Personalized Medicines Products, Services, and Solutions

Table 54. Revenue (US$ Million) in Personalized Medicines Business of Agendia NV (2021–2026)

Table 55. Agendia NV Recent Developments

Table 56. Asuragen Inc Basic Information List

Table 57. Asuragen Inc Description and Business Overview

Table 58. Asuragen Inc Personalized Medicines Products, Services, and Solutions

Table 59. Revenue (US$ Million) in Personalized Medicines Business of Asuragen Inc (2021–2026)

Table 60. Asuragen Inc Recent Developments

Table 61. Becton Dickinson Basic Information List

Table 62. Becton Dickinson Description and Business Overview

Table 63. Becton Dickinson Personalized Medicines Products, Services, and Solutions

Table 64. Revenue (US$ Million) in Personalized Medicines Business of Becton Dickinson (2021–2026)

Table 65. Becton Dickinson Recent Developments

Table 66. CardioDx Inc. Basic Information List

Table 67. CardioDx Inc. Description and Business Overview

Table 68. CardioDx Inc. Personalized Medicines Products, Services, and Solutions

Table 69. Revenue (US$ Million) in Personalized Medicines Business of CardioDx Inc. (2021–2026)

Table 70. CardioDx Inc. Recent Developments

Table 71. Foundation Medicine Basic Information List

Table 72. Foundation Medicine Description and Business Overview

Table 73. Foundation Medicine Personalized Medicines Products, Services, and Solutions

Table 74. Revenue (US$ Million) in Personalized Medicines Business of Foundation Medicine (2021–2026)

Table 75. Foundation Medicine Recent Developments

Table 76. Qiagen Basic Information List

Table 77. Qiagen Description and Business Overview

Table 78. Qiagen Personalized Medicines Products, Services, and Solutions

Table 79. Revenue (US$ Million) in Personalized Medicines Business of Qiagen (2021–2026)

Table 80. Qiagen Recent Developments

Table 81. Siemens Healthcare Basic Information List

Table 82. Siemens Healthcare Description and Business Overview

Table 83. Siemens Healthcare Personalized Medicines Products, Services, and Solutions

Table 84. Revenue (US$ Million) in Personalized Medicines Business of Siemens Healthcare (2021–2026)

Table 85. Siemens Healthcare Recent Developments

Table 86. Amgen Basic Information List

Table 87. Amgen Description and Business Overview

Table 88. Amgen Personalized Medicines Products, Services, and Solutions

Table 89. Revenue (US$ Million) in Personalized Medicines Business of Amgen (2021–2026)

Table 90. Amgen Recent Developments

Table 91. Bristol-Myers Squibb Basic Information List

Table 92. Bristol-Myers Squibb Description and Business Overview

Table 93. Bristol-Myers Squibb Personalized Medicines Products, Services, and Solutions

Table 94. Revenue (US$ Million) in Personalized Medicines Business of Bristol-Myers Squibb (2021–2026)

Table 95. Bristol-Myers Squibb Recent Developments

Table 96. GE Healthcare Basic Information List

Table 97. GE Healthcare Description and Business Overview

Table 98. GE Healthcare Personalized Medicines Products, Services, and Solutions

Table 99. Revenue (US$ Million) in Personalized Medicines Business of GE Healthcare (2021–2026)

Table 100. GE Healthcare Recent Developments

Table 101. Pfizer Basic Information List

Table 102. Pfizer Description and Business Overview

Table 103. Pfizer Personalized Medicines Products, Services, and Solutions

Table 104. Revenue (US$ Million) in Personalized Medicines Business of Pfizer (2021–2026)

Table 105. Pfizer Recent Developments

Table 106. Sanofi Basic Information List

Table 107. Sanofi Description and Business Overview

Table 108. Sanofi Personalized Medicines Products, Services, and Solutions

Table 109. Revenue (US$ Million) in Personalized Medicines Business of Sanofi (2021–2026)

Table 110. Sanofi Recent Developments

Table 111. 23andMe Basic Information List

Table 112. 23andMe Description and Business Overview

Table 113. 23andMe Personalized Medicines Products, Services, and Solutions

Table 114. Revenue (US$ Million) in Personalized Medicines Business of 23andMe (2021–2026)

Table 115. 23andMe Recent Developments

Table 116. Illumina Basic Information List

Table 117. Illumina Description and Business Overview

Table 118. Illumina Personalized Medicines Products, Services, and Solutions

Table 119. Revenue (US$ Million) in Personalized Medicines Business of Illumina (2021–2026)

Table 120. Illumina Recent Developments

Table 121. Revenue (US$ Million) in Personalized Medicines Business of Company 40 (2021–2026)

Table 122. Company 40 Recent Developments

Table 123. Key Raw Materials Lists

Table 124. Key Suppliers of Raw Materials Lists

Table 125. Personalized Medicines Downstream Customers

Table 126. Personalized Medicines Distributors List

Table 127. Research Programs/Design for This Report

Table 128. Key Data Information from Secondary Sources

Table 129. Key Data Information from Primary Sources

List of Figures

Figure 1. Personalized Medicines Product Picture

Figure 2. Global Personalized Medicines Sales Value, 2021 vs 2025 vs 2032 (US$ Million)

Figure 3. Global Personalized Medicines Sales Value (US$ Million), 2021–2032

Figure 4. Personalized Medicines Report Years Considered

Figure 5. Global Personalized Medicines Players Revenue Ranking (US$ Million), 2025

Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Personalized Medicines Revenue in 2025

Figure 7. Personalized Medicines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 8. PM Diagnostics Picture

Figure 9. PM Therapeutics Picture

Figure 10. Personalized Medical Care Picture

Figure 11. Personalized Nutrition & Wellness Picture

Figure 12. Global Personalized Medicines Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032

Figure 13. Global Personalized Medicines Sales Value Market Share by Type, 2025 & 2032

Figure 14. Product Picture of Hospitals Pharmacies

Figure 15. Product Picture of Retail Pharmacies

Figure 16. Product Picture of Dietary Care Centers

Figure 17. Product Picture of Others

Figure 18. Global Personalized Medicines Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032

Figure 19. Global Personalized Medicines Sales Value Market Share by Application, 2025 & 2032

Figure 20. North America Personalized Medicines Sales Value (US$ Million), 2021–2032

Figure 21. North America Personalized Medicines Sales Value by Country (%), 2025 vs 2032

Figure 22. Europe Personalized Medicines Sales Value (US$ Million), 2021–2032

Figure 23. Europe Personalized Medicines Sales Value by Country (%), 2025 vs 2032

Figure 24. Asia Pacific Personalized Medicines Sales Value (US$ Million), 2021–2032

Figure 25. Asia Pacific Personalized Medicines Sales Value by Subregion (%), 2025 vs 2032

Figure 26. South America Personalized Medicines Sales Value (US$ Million), 2021–2032

Figure 27. South America Personalized Medicines Sales Value by Country (%), 2025 vs 2032

Figure 28. Middle East & Africa Personalized Medicines Sales Value (US$ Million), 2021–2032

Figure 29. Middle East & Africa Personalized Medicines Sales Value by Country (%), 2025 vs 2032

Figure 30. Key Countries/Regions Personalized Medicines Sales Value (%), 2021–2032

Figure 31. United States Personalized Medicines Sales Value (US$ Million), 2021–2032

Figure 32. United States Personalized Medicines Sales Value by Type (%), 2025 vs 2032

Figure 33. United States Personalized Medicines Sales Value by Application (%), 2025 vs 2032

Figure 34. Europe Personalized Medicines Sales Value (US$ Million), 2021–2032

Figure 35. Europe Personalized Medicines Sales Value by Type (%), 2025 vs 2032

Figure 36. Europe Personalized Medicines Sales Value by Application (%), 2025 vs 2032

Figure 37. China Personalized Medicines Sales Value (US$ Million), 2021–2032

Figure 38. China Personalized Medicines Sales Value by Type (%), 2025 vs 2032

Figure 39. China Personalized Medicines Sales Value by Application (%), 2025 vs 2032

Figure 40. Japan Personalized Medicines Sales Value (US$ Million), 2021–2032

Figure 41. Japan Personalized Medicines Sales Value by Type (%), 2025 vs 2032

Figure 42. Japan Personalized Medicines Sales Value by Application (%), 2025 vs 2032

Figure 43. South Korea Personalized Medicines Sales Value (US$ Million), 2021–2032

Figure 44. South Korea Personalized Medicines Sales Value by Type (%), 2025 vs 2032

Figure 45. South Korea Personalized Medicines Sales Value by Application (%), 2025 vs 2032

Figure 46. Southeast Asia Personalized Medicines Sales Value (US$ Million), 2021–2032

Figure 47. Southeast Asia Personalized Medicines Sales Value by Type (%), 2025 vs 2032

Figure 48. Southeast Asia Personalized Medicines Sales Value by Application (%), 2025 vs 2032

Figure 49. India Personalized Medicines Sales Value (US$ Million), 2021–2032

Figure 50. India Personalized Medicines Sales Value by Type (%), 2025 vs 2032

Figure 51. India Personalized Medicines Sales Value by Application (%), 2025 vs 2032

Figure 52. Personalized Medicines Value Chain

Figure 53. Personalized Medicines Cost Structure

Figure 54. Channels of Distribution (Direct Sales, and Distribution)

Figure 55. Bottom-up and Top-down Approaches for This Report

Figure 56. Data Triangulation

Figure 57. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Personalized Medicines market? zhanKai

The top companies in the global Personalized Medicines market are 3G Biotech、Quest Diagnostics、Laboratory Corporation of America.

What was the global market size of Personalized Medicines in 2032? shouQi

What is the annual compound growth rate of the global Personalized Medicines market size from 2026 to 2032? shouQi

Which region is expected to have the highest market share? shouQi

What was the global market size of Personalized Medicines in 2026? shouQi

Related Reports

Global Personalized Medicines Market Research Report 2026
The global Personalized Medicines market was valued at US$ 350760 million in 2025 and is anticipated to reach US$ 714300 million by 2032, at a CAGR of 10.9% from 2026 to 2032.
Published Date: 2026-04-28
Pages: 129
USD 2900.00
(Single User License)
Global Personalized Medicines Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Personalized Medicines market size was US$ 319550 million in 2024 and is forecast to a readjusted size of US$ 650760 million by 2031 with a CAGR of 10.9% during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 101
USD 4250.00
(Single User License)
Global Personalized Medicines Market Research Report 2025
The global market for Personalized Medicines was valued at US$ 319550 million in the year 2024 and is projected to reach a revised size of US$ 650760 million by 2031, growing at a CAGR of 10.9% during the forecast period.
Published Date: 2025-02-27
Pages: 96
USD 2900.00
(Single User License)
Personalized Medicines- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Personalized Medicines was estimated to be worth US$ 319550 million in 2024 and is forecast to a readjusted size of US$ 650760 million by 2031 with a CAGR of 10.9% during the forecast period 2025-2031.
Published Date: 2025-02-27
Pages: 137
USD 3950.00
(Single User License)
Global Personalized Medicines Market Insights, Forecast to 2030
Personalized medicine is tailoring of a treatment to a specific patient i.e. designing medicine treatment on the basis of diagnosis, disease condition, patient history, body physics, and other factors related to patients and diseases. Personalized medicine is also known as precision medicine, stratified medicine, or P4 medicine.
Published Date: 2024-04-25
Pages: 117
USD 4900.00
(Single User License)
Personalized Medicines - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Personalized medicine is tailoring of a treatment to a specific patient i.e. designing medicine treatment on the basis of diagnosis, disease condition, patient history, body physics, and other factors related to patients and diseases. Personalized medicine is also known as precision medicine, stratified medicine, or P4 medicine.
Published Date: 2024-01-24
Pages: 123
USD 3950.00
(Single User License)
Global Personalized Medicines Market Research Report 2024
Personalized medicine is tailoring of a treatment to a specific patient i.e. designing medicine treatment on the basis of diagnosis, disease condition, patient history, body physics, and other factors related to patients and diseases. Personalized medicine is also known as precision medicine, stratified medicine, or P4 medicine.
Published Date: 2024-01-11
Pages: 91
USD 2900.00
(Single User License)

Global Personalized Medicines Market Research Report 2026
The global Personalized Medicines market was valued at US$ 350760 million in 2025 and is anticipated to reach US$ 714300 million by 2032, at a CAGR of 10.9% from 2026 to 2032.
Published: 2026-04-28
Pages: 129
USD 2900.00 (Single User License)
Global Personalized Medicines Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Personalized Medicines market size was US$ 319550 million in 2024 and is forecast to a readjusted size of US$ 650760 million by 2031 with a CAGR of 10.9% during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 101
USD 4250.00 (Single User License)
Global Personalized Medicines Market Research Report 2025
The global market for Personalized Medicines was valued at US$ 319550 million in the year 2024 and is projected to reach a revised size of US$ 650760 million by 2031, growing at a CAGR of 10.9% during the forecast period.
Published: 2025-02-27
Pages: 96
USD 2900.00 (Single User License)
Personalized Medicines- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Personalized Medicines was estimated to be worth US$ 319550 million in 2024 and is forecast to a readjusted size of US$ 650760 million by 2031 with a CAGR of 10.9% during the forecast period 2025-2031.
Published: 2025-02-27
Pages: 137
USD 3950.00 (Single User License)
Global Personalized Medicines Market Insights, Forecast to 2030
Personalized medicine is tailoring of a treatment to a specific patient i.e. designing medicine treatment on the basis of diagnosis, disease condition, patient history, body physics, and other factors related to patients and diseases. Personalized medicine is also known as precision medicine, stratified medicine, or P4 medicine.
Published: 2024-04-25
Pages: 117
USD 4900.00 (Single User License)
Personalized Medicines - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Personalized medicine is tailoring of a treatment to a specific patient i.e. designing medicine treatment on the basis of diagnosis, disease condition, patient history, body physics, and other factors related to patients and diseases. Personalized medicine is also known as precision medicine, stratified medicine, or P4 medicine.
Published: 2024-01-24
Pages: 123
USD 3950.00 (Single User License)
Global Personalized Medicines Market Research Report 2024
Personalized medicine is tailoring of a treatment to a specific patient i.e. designing medicine treatment on the basis of diagnosis, disease condition, patient history, body physics, and other factors related to patients and diseases. Personalized medicine is also known as precision medicine, stratified medicine, or P4 medicine.
Published: 2024-01-11
Pages: 91
USD 2900.00 (Single User License)